These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26015977)

  • 1. Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox).
    Brendel C; Kaufmann KB; Krattenmacher A; Pahujani S; Grez M
    Mol Ther Methods Clin Dev; 2014; 1():14037. PubMed ID: 26015977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H; Ishibashi F
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.
    Chiriaco M; Farinelli G; Capo V; Zonari E; Scaramuzza S; Di Matteo G; Sergi LS; Migliavacca M; Hernandez RJ; Bombelli F; Giorda E; Kajaste-Rudnitski A; Trono D; Grez M; Rossi P; Finocchi A; Naldini L; Gentner B; Aiuti A
    Mol Ther; 2014 Aug; 22(8):1472-1483. PubMed ID: 24869932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
    Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
    Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
    Nunoi H; Ishibashi F
    Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization and transduction of CD34(+) peripheral blood stem cells in patients with X-linked chronic granulomatous disease.
    Ott MG; Merget-Millitzer H; Ottmann OG; Martin H; Brüggenolte N; Bialek H; Seger R; Hossle JP; Hoelzer D; Grez M
    J Hematother Stem Cell Res; 2002 Aug; 11(4):683-94. PubMed ID: 12201957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
    Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
    Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
    Chiriaco M; Salfa I; Di Matteo G; Rossi P; Finocchi A
    Pediatr Allergy Immunol; 2016 May; 27(3):242-53. PubMed ID: 26680691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
    Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
    Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47
    Schejtman A; Vetharoy W; Choi U; Rivat C; Theobald N; Piras G; Leon-Rico D; Buckland K; Armenteros-Monterroso E; Benedetti S; Ashworth MT; Rothe M; Schambach A; Gaspar HB; Kang EM; Malech HL; Thrasher AJ; Santilli G
    Hum Gene Ther; 2021 Sep; 32(17-18):949-958. PubMed ID: 33740872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Generation of Functional Neutrophils and Macrophages from Patient-Specific Induced Pluripotent Stem Cells: Ex Vivo Models of X(0)-Linked, AR22(0)- and AR47(0)- Chronic Granulomatous Diseases.
    Brault J; Goutagny E; Telugu N; Shao K; Baquié M; Satre V; Coutton C; Grunwald D; Brion JP; Barlogis V; Stephan JL; Plantaz D; Hescheler J; Krause KH; Sarić T; Stasia MJ
    Biores Open Access; 2014 Dec; 3(6):311-26. PubMed ID: 25469316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.
    Stein S; Scholz S; Schwäble J; Sadat MA; Modlich U; Schultze-Strasser S; Diaz M; Chen-Wichmann L; Müller-Kuller U; Brendel C; Fronza R; Kaufmann KB; Naundorf S; Pech NK; Travers JB; Matute JD; Presson RG; Sandusky GE; Kunkel H; Rudolf E; Dillmann A; von Kalle C; Kühlcke K; Baum C; Schambach A; Dinauer MC; Schmidt M; Grez M
    Hum Gene Ther Clin Dev; 2013 Jun; 24(2):86-98. PubMed ID: 23845071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study.
    Violi F; Sanguigni V; Carnevale R; Plebani A; Rossi P; Finocchi A; Pignata C; De Mattia D; Martire B; Pietrogrande MC; Martino S; Gambineri E; Soresina AR; Pignatelli P; Martino F; Basili S; Loffredo L
    Circulation; 2009 Oct; 120(16):1616-22. PubMed ID: 19805647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked chronic granulomatous disease in a male child with an X-CGD carrier, Klinefelter brother.
    Gill HK; Kumar HC; Cheng CK; Ming CC; Nallusamy R; Yusoff NM; Mohamad SB; Ripen AM; Dhaliwal JS; Murad S
    Asian Pac J Allergy Immunol; 2013 Jun; 31(2):167-72. PubMed ID: 23859418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
    Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M
    Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of chronic granulomatous disease.
    Grez M; Becker S; Saulnier S; Knöss H; Ott MG; Maurer A; Dinauer MC; Hoelzer D; Seger R; Hossle JP
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S99-104. PubMed ID: 10933200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.